Shigella dysenteriae

This article is currently being developed as part of an Eduzendium student project. If you are not involved with this project, please refrain from collaboratively developing it until this notice is removed. Articles that lack this notice, including many Eduzendium ones, welcome your collaboration!

Scientific classification
Kingdom: Eubacteria Phylum: Proteobacteria Class: Gamma Proteobacteria Order: Enterobacteriales Family: Enterobacteriaceae Genus: Shigella Species: dysenteriae
Binomial name
Shigella dysenteriae

Description and significance

Describe the appearance, habitat, etc. of the organism, and why it is important enough to have its genome sequenced. Describe how and where it was isolated. Include a picture or two (with sources) if you can find them.

[[1]]

Shigella was discovered over 100 hundred years ago by the Japanese microbiologist Shiga, which the genus was named after. The genus Shigella includes four species, boydii, dysenteriae, flexneri, and sonnei. Shigella dysenteriae is gram-negative. Shigella dysenteriae are uncapsualted, rod (bacillus) shaped, non-motile, non-spore-forming, facultative anaerobic bacteria. The bacteria is able to survive contaminated environments as well as the acidity of the human gastro-intestinal tract. The accumulation of bacterial Shigella dysenteriae is known to cause a condition known as shigellosis.

Genome structure

Describe the size and content of the genome. How many chromosomes? Circular or linear? Other interesting features? What is known about its sequence? Does it have any plasmids? Are they important to the organism's lifestyle?

Shigella dysenteriae has the smallest genome out of the genus Shigella, which contains three other species. It's genome consists of a single circular chromosome and 4,369,232 base pairs. It carries an invasion-associated plasmid which contains genes that code for the invasion of the epithelial cells and the production of Shiga toxin. The Shiga toxin is a potent A-B type toxin with 1-A and 5-B subunits. B subunits bind to the cell and inject the A-subunit. By cleaving a specific adenine residue from the 28S ribosomal RNA in the 60S ribosome, the toxin inhibits protein synthesis, causing cell death.

Cell structure and metabolism

Describe any interesting features and/or cell structures; how it gains energy; what important molecules it produces

Shigella dysenteriae ferments glucose via mixed acid fermentation, however it does not produce any gas. It does not produce H₂S, phenylalaninedeaminase or urease and does not use citrate as a sole carbon source. They ferment only a few cabohydrates.

Shiga Toxin

_{This is an image showing the crystalline structure of Shiga toxin. The bottom represents the beta subunits and the top represents the alpha subunits}.

Shigella dysenteriae, produces Shiga toxin. Shiga toxin has a cytotoxic effect on intestinal epithelial cells. Shiga toxin has a molecular weight of 68,000 daltons. The structure of the toxin is comprised of two types of subunits, alpha subunits and beta subunits. Beta subunits are responsible for binding to the host cell, whereas alpha subunits are responsible for poisoning the host cell.

Shiga Toxin Mechanism

Shiga toxin attacks the surface of blood vessels inside the gastro-intestinal tract. The beta subunits of the Shiga toxin bind to the host cell. The alpha subunits are then injected into the cell, and these subunits work inhibit protein synthesis by deactivating the ribosomes. This eventually leads to the death of the cell, and hemmorrhage of the surface whcich it binds to. This accounts for the blood seen in the diarrhea. The toxin not only affect the digestive tract, but it attacks major structures associated with the kidneys function. The attack on these structures leads to kidney failure and the development of Hemolytic Uremic Syndrome.

Ecology

Describe any interactions with other organisms (included eukaryotes), contributions to the environment, effect on environment, etc.

The only organisms that Shigella dysenteriae interacts with are humans, but other primates as well, and flies. Humans act as hosts for infection, which leads to bacillary dysentery. Flies can act as means of transportation for the bacteria, spreading it to other hosts.

Shigella dysenteriae can survive in faecally contaminated materials which can include water, foods, and other materials. It can be transmitted by person to person contact. It is generally transmitted with the ingestion of water and food contaminated with the bacteria. It can cause foodborne or waterborne epidemics. Water may become contaminated even if someone who has Shigellosis swims in it. Crops can be contaminated with the bacteria if they are watered with contaminated water. This will cause major problems if these contaminated crops are then distributed over a large region, exposing anyone who eats the crops to infection. Epidemics are more likely in poorer countries without adequate sanitation and water treatment systems.

Pathology

How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms.

Shigella dysenteriae causes shigellosis (bacillary dysentery) in humans. It's also known to cause dysentery in other primates, but not in other animals. The infection can be caused by as little as 10 bacterial cells, whereas as other bacteria requires millions on cells for infection. This is due to the potency of the Shiga toxin. The infection begins with the bacteria entering the gastro-intestinal tract attaching itself to the intestinal wall. The bacteria invades the host cell injecting its Shiga toxin inside. This results in the degeneration of of the surface, causing blood leakage. Water will no longer be able to be absorbed, which results in dehydration.

Common symptoms of bacillary dysentery include acute bloody diarrhea, abdominal pains and cramps, fever, vomiting, dehydration, and tenesmus. A more severe infection can lead to more severe complications such as hemolytic uremic syndrome, which develops in 5 to 10 percent of patients. Mortality from hemolytic uremic syndrome approaches 5 percent, but up to 30 percent of patients who survive have chronic renal disease. Patients, in more severe cases, can also suffer from inflammatory colitis.

Shigellosis can resolve on its own in several days, but in smaller children and people with weak immune systems, the infection can be more severe, resulting in hospitalization or death. Once a person has become infected, they are not likely to get infected with the particular strain again, due to the bodies ability to produce antibodies. However, they can be reinfected by other strains of Shigella dysenteriae. Treatment includes the application of antibiotics. The antibiotics will kill the bacteria inside the gastrointerstinal tract, shortening its lifespan and therefore shortening the course of the infection. Some anitmicrobial agents used to treat bacillary desentery include, ciprofloxacin, ampicillin, trimethoprim-sulfamethoaxzole, and nalidixic acid. Other medication is used to treat other effect of the dysentery such as dehydration.

Current Research

Enter summaries of the most recent research here--at least three required

Recent studies have shown that Shigella dysenteriae, as well as other species within the genus, are becoming significantly more resistance to antibiotics in the United States. This resistance has made cases of infection by Shigella dysenteriae more difficult to treat, especially in children. Shigella are becoming more resistant to treatments which use ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX). Shigella isolates were surveyed over a period of four years, and the there was a common trend in increasing rates of resistance to these animicrobial agents. Shigella dysenteriae isolates are also developing a resistance to nalidixic acid. It was also found that these resistances were not limited to the United states. Shigella dysenteriae isolates are becoming more resistant to antimicrobial agents in other parts of the world as well.

It has been found that Shigella dysenteriae's virulence is regulated by RyhB suppression. The virulence genes that are being repressed by RyhB includes genes which code for the secretion apparatus, its effectors and its chaperones. It was found that the virulence suppression was occurs by the RyhB dependent repression of the transcriptional activator VirB which lead a reduction in expression of genes within the VirB region. Several tests were conducted such as microarray analysis, secreted protein analysis and Polymerase Chain Reaction. It was concluded that RyhB represses the expression of several genes within VirB region, which in turn, suppresses plaque formation by inhibiting the ability of Shigella dysenteriae to invade eukaryotic cells. There is a direct relationship between plaque formation and RyhB expression. It was then further determined that since RyhB is iron-responsive, iron, therefore contributes to the regulation of virulence within Shigella dysenteriae.

There has been one case of Shigellosis discovered in which the patient suffered from septic shock and convulsions, which is an unusual side effect of the infection. The patient had the usual symptoms of bloody diarhhea, tenesmus and fever. The patient also suffered from abnormal body movement and did not respond to the initial treatments with trimethoprim-sulphamethoxazole, which suggests that the particular strain of the infection was resistant to the antibiotic. Various tests, such as blood films, stool microscopy, stool culture and cerebrospinal fluid cultures, were conducted to determine the cause of this case of Shigellosis, but all came up negative. Finally, a tests was done on the blood culture and after a few days colony growth was observed and Shigella dysenteriae was isolated. Sensitivity test were then conducted on the bacteria. It was determined that the bacteria was resistant to chloramphenicol, TMP-SMX, ampicillin, and tetracycline, but sensitive to ciprofloxacin and gentamycin. The patient was given medication for the septic shock, which subsided soon afterward. However, the patient died soon after. It was thought that the septic shock was a result of the build up of Shiga toxin produced by the bacteria. It was concluded that when not appropriately and promptly treated, these infections can lead to more serious and lethal side effects.

References

[Sample reference] Takai, K., Sugai, A., Itoh, T., and Horikoshi, K. "Palaeococcus ferrophilus gen. nov., sp. nov., a barophilic, hyperthermophilic archaeon from a deep-sea hydrothermal vent chimney". International Journal of Systematic and Evolutionary Microbiology. 2000. Volume 50. p. 489-500.

2008 Kenneth Todar University of Wisconsin-Madison Department of Bacteriology, Shigella and Shigellosis

Shigella dysenteriae, KEGG Genome

MicroBioNet: Bacteriology - Shigella

Joyann A Kroser, MD, Clinical Associate Professor of Medicine, Department of Internal Medicine, Division of Gastroenterology, Drexel University College of Medicine, Shigellosis, eMedicine from WebMD

Shigella dysenteriae(bacillary dysentery), Historique.net: Infectious Disease

Bower JR. Foodborne diseases: shiga toxin producing E. coli (STEC). Pediatr Infect Dis J October 1999;18:909-10.

George Abramochkin, Shigella spp., 05.15.2004

Journal Articles

Sumathi Sivapalasingam,1,2* Jennifer M. Nelson,1 Kevin Joyce,1 Mike Hoekstra,3 Frederick J. Angulo,1 and Eric D. Mintz1, "High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002", Antimicrob Agents Chemother. 2006 January; 50(1): 49–54. doi: 10.1128/AAC.50.1.49-54.2006. PMCID: PMC1346809

Murphy ER, Payne SM., University of Texas at Austin, Section of Molecular Genetics and Microbiology, 1 University Station A5000, Austin, TX 78712, USA., "RyhB, an iron-responsive small RNA molecule, regulates Shigella dysenteriae virulence". Infect Immun. 2007 Jul;75(7):3470-7. Epub 2007 Apr 16., PMID: 17438026 PubMed - indexed for MEDLINE

Sebhat A. Erqou, Endale Teferra1, Andargachew Mulu and Afework Kassu*, Department of Microbiology and Parasitology and 1Department of Pediatrics and Child Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia, "A Case of Shigellosis with Intractable Septic Shock and Convulsions", Jpn. J. Infect. Dis., 60 (5), 314-316, 2007(Received February 23, 2007. Accepted June 4, 2007)

2. http://www.genome.jp/kegg-bin/show_organism?org=sdy

3. http://www.microbionet.com.au/shigella.htm

5. http://pathport.vbi.vt.edu/pathinfo/pathogens/Shigella.html

6. http://microbes.historique.net/dysenteriae.html

7. http://www.aafp.org/afp/20000401/tips/11.html